NFKB1 and diabetes mellitus: Tripdiolide treatment significantly decreased TLR4 by 45.3%, P-NF-κB by 54.9%, and NLRP3 by 30.7% in the kidney of diabetes mice (p < 0.05) (Figure 5B).